A trial to learn how safe anifrolumab is, how it moves throughout the body over time, and how it affects the body of adults with systemic lupus erythematosus
Systemic lupus erythematosus, often just called lupus, is a long-term condition where the immune system mistakenly attacks healthy tissues, causing symptoms like joint pain, extreme tiredness, and skin rashes. This early-stage study is testing a medicine called anifrolumab in adults who have lupus. Researchers want to learn three main things: how safe the medicine is, how it moves through the body over time (pharmacokinetics), and how it affects the immune system (pharmacodynamics). Because this is an early pharmacology trial, the main focus is gathering precise biological information rather than proving long-term cure rates. Volunteers will receive the study drug and undergo regular health checks, including blood and urine tests. Taking part is completely voluntary. The findings from this research will help doctors understand how to use anifrolumab safely and effectively for lupus patients in the future.
At a glance
What is this study about?
Systemic lupus erythematosus (SLE) is an autoimmune condition. In a healthy body, the immune system makes proteins called antibodies to fight off bugs and viruses. In someone with lupus, the immune system gets confused and attacks healthy parts of the body instead. This can lead to swelling, joint pain, rashes, kidney problems, and severe fatigue. Managing lupus can be difficult, and doctors are always looking for better, more targeted treatments.
Anifrolumab is a treatment designed to block a specific pathway in the immune system called type I interferon, which is often overactive in people with lupus. By calming this pathway, researchers hope to reduce the harmful inflammation that causes lupus symptoms.
This trial is an early-stage pharmacology study. Before a medicine can be widely prescribed or used in new ways, scientists must understand exactly what happens to it inside the human body. They need to track how quickly the body absorbs the medicine, where it travels, how it breaks down, and how it leaves the body.
By taking part, participants help provide vital clues about the best doses to use and what side effects to watch out for. Even though this trial may not directly improve a volunteer's own health, the knowledge gained will play an important role in developing better care for people living with lupus worldwide.
Key takeaways
- The trial looks at how the lupus medicine anifrolumab moves through and affects the body.
- Open to adults aged 18 and over with systemic lupus erythematosus.
- Involves clinic visits, receiving the medicine, and regular blood tests to check drug levels.
- Focuses on drug safety and pharmacology rather than long-term symptom relief.
- Participation is completely voluntary, and you can withdraw at any time.
Who may be eligible?
This study is open to men and women aged 18 and older who have been diagnosed with systemic lupus erythematosus (SLE). Because this trial focuses on how the body processes the medicine, researchers need adults whose diagnosis is clear and whose general health allows them to take part safely.
People might not be able to join if they have other serious health problems, such as severe heart, liver, or kidney disease that is not related to their lupus. You may also be unable to take part if you currently have a serious infection, a history of certain cancers, or if you are taking specific medications that could clash with the study drug.
Women who are pregnant, planning to become pregnant, or breastfeeding will usually not be eligible, as the effects of the study drug on unborn or newborn babies are not fully known. The trial doctor will review your full medical history to confirm whether it is safe for you to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am at least 18 years old.
- I have a confirmed medical diagnosis of systemic lupus erythematosus (SLE).
- I do not currently have a severe, active infection.
- I am not pregnant or breastfeeding, and I am willing to use reliable contraception if required.
- I am able and willing to attend regular hospital appointments for check-ups and blood tests.
What does participation involve?
If you decide to join this study, you will first attend a screening visit to check your overall health and confirm that the trial is suitable for you. This will involve physical examinations, heart traces (ECGs), and routine blood and urine samples.
During the study, you will receive the study drug, anifrolumab. This is typically given as a slow drip into a vein (an intravenous infusion) or as an injection under the skin. You will need to stay at the clinic for monitoring after receiving the dose so doctors can watch for any immediate reactions.
Over the following weeks or months, you will have several scheduled clinic visits. At these visits, the research team will take regular blood samples to measure the exact amount of medicine in your body at different times. They will also monitor your lupus symptoms, check your vital signs, and ask how you are feeling. The trial team will explain the exact visit schedule and overall time commitment before you agree to take part.
Potential risks and benefits
Locations (2)
- —UnverifiedPoland
- —UnverifiedHungary
Common questions
Will taking part in this study cure my lupus?
No, this trial is not expected to cure lupus. It is designed to help scientists understand how anifrolumab behaves in the body, which will help improve future treatment plans.
Will I have to pay for the study medicine?
No. All study medicines, clinic visits, and tests linked to the trial are provided free of charge. Travel expenses are also often reimbursed.
Do I have to stop seeing my usual rheumatologist?
No. Your regular doctor will stay informed about your care, and you will return to your standard NHS treatment plan once your time in the study is finished.
What happens if I experience side effects?
You will have direct contact details for the research team. If you feel unwell or notice any new symptoms, they are available to assess and support you immediately.
Can I leave the study early if I change my mind?
Yes. You have the right to withdraw from the trial at any point, for any reason, and your regular medical care will not be affected in any way.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.